The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis
PsiquiatriaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Progress in neuro-psychopharmacology & biological psychiatry
- Publicado em
- 18 jul 2025
- Citações
- 12
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
The role of GABA, glutamate, and Glx levels in treatment of major depressive disorder: A systematic review and meta-analysis
Kate Godfrey, Hannah Douglass, David Erritzoe, Suresh Muthukumaraswamy, David Nutt, Rachael Sumner
Descritores MeSH
- gamma-Aminobutyric Acid
- Glutamine
- Glutamic Acid
- Major Depressive Disorder
- Treatment Outcome
- Selective Serotonin Reuptake Inhibitors
- Transcranial Magnetic Stimulation
- Electroconvulsive Therapy
- Humans
- Magnetic Resonance Spectroscopy
Veja também
Estudos relacionados
- Ultra-high field magnetic resonance spectroscopy study of transcranial magnetic stimulation treatment in adolescents with depression
- A Meta-Analysis of Magnetic Resonance Spectroscopy Studies on Glutamatergic Neurometabolite Levels in Major Depressive Disorder
- The Glutamatergic Effects of Clinical Repetitive Transcranial Magnetic Stimulation in Depressed Populations: A Preliminary Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies
- Repetitive Transcranial Magnetic Stimulation-Associated Changes in Neocortical Metabolites in Major Depression: A Systematic Review